LivaNova Director Sells Shares Worth $131,500
On August 31, 2026, LivaNova director Francesco Bianchi sold 1,650 shares of the company at a weighted average price of $79.72 per share, totaling $131,500 in transaction value. The sale represented approximately 17% of his directly held equity stake prior to the transaction and reduced his holdings from 9,584 to 7,934 shares. LivaNova operates primarily through its Cardiopulmonary and Neuromodulation segments, offering products such as heart-lung machines and vagus nerve stimulation systems. The company reported a market capitalization of $4.3 billion with trailing twelve-month revenue of $1.5 billion and net income of $188.6 million. The insider sale occurred at slightly below the closing price on August 31, which was $79.81 per share, compared to $80.16 as of September 1.
Tickers: $LIVN
Topics: director sale LivaNova SEC Form 4